Activation of STING signaling is linked to other neurodegenerative diseases, and inhibiting STING activation protects against deleterious effects of IFN responses in Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis11–13. This evidence concerns the gene STING1 and Parkinson disease.